Security key
98400H102
XBiotech Inc. - Common Shares, no par value (XBIT)
CUSIP: 98400H102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 3,415,938
- Total 13F value
- $10,142,998
- Share change
- -1,066,410
- SEC-reported price per share
- $2.97
- Number of holders
- 51
- Value change
- -$3,226,972
- Number of buys
- 26
- Number of sells
- 36
- Shares outstanding
- 32,315,113
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
51
Top holders
10
XBIT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
XBiotech Inc. SEC filings
XBiotech Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98400H102
Recent filing periods:
Ownership snapshot
Top reported holders of XBIT - XBiotech Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 4%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
4%
VANGUARD GROUP INC
3.3%
GEODE CAPITAL MANAGEMENT, LLC
1.4%
STATE STREET CORP
0.71%
NORTHERN TRUST CORP
0.65%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
Company
|
4%
|
$4,165,873
1,285,763 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$3,443,381
1,062,772 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$1,494,812
461,230 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
0.71%
|
$744,212
229,695 shares
|
— | 31 Mar 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.65%
|
$677,973
209,251 shares
|
— | 31 Mar 2025 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.38%
|
$398,624
123,032 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
3,415,938
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
54
Q2 2025 holders
51
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend